III Q1 2026 Earnings EPS Surpasses Estimates by 17 as Stock Edges Higher XENE Q1 2026 Earnings Narrower Net Loss Highlights Clinical and Strategic Progress SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment RCL Q1 2026 Earnings Strong EPS Beat Drives Market Optimism HROW Q1 2026 Earnings EPS Misses Estimates Significantly as Company Navigates Operational Challenges UPBD Q1 2026 Earnings EPS Beats Estimates by 247